Determinants of household catastrophic costs for drug sensitive tuberculosis patients in Kenya

• Published in: Infectious diseases of poverty 2021-07, Vol.10 (1), p.1-95, Article 95
• Main Authors: Kirubi, Beatrice, Ong'ang'o, Jane, Nguhiu, Peter, Lönnroth, Knut, Rono, Aiban, Sidney-Annerstedt, Kristi
• Format: Article
• Language: English
• Subjects: Analysis; Antitubercular agents; Costs; Economic aspects; Family income; Health expenditure; Health promotion; Hospitals; Households; Income loss; Kenya; Medical care, Cost of; Medical research; Medicin och hälsovetenskap; Medicine, Experimental; Patients; Population; Poverty; Public health; Questionnaires; Regression analysis; Sensitivity analysis; Social protection; Surveys; Tuberculosis
• ISSN: 2049-9957; 2095-5162; 2049-9957
• DOI: 10.1186/s40249-021-00879-4

Background Despite free diagnosis and treatment for tuberculosis (TB), the costs during treatment impose a significant financial burden on patients and their households. The study sought to identify the determinants for catastrophic costs among patients with drug-sensitive TB (DSTB) and their households in Kenya. Methods The data was collected during the 2017 Kenya national patient cost survey from a nationally representative sample (n = 1071). Treatment related costs and productivity losses were estimated. Total costs exceeding 20% of household income were defined as catastrophic and used as the outcome. Multivariable Poisson regression analysis was performed to measure the association between selected individual, household and disease characteristics and occurrence of catastrophic costs. A deterministic sensitivity analysis was carried using different thresholds and the significant predictors were explored. Results The proportion of catastrophic costs among DSTB patients was 27% (n = 294). Patients with catastrophic costs had higher median productivity losses, 39 h [interquartile range (IQR): 20-104], and total median costs of USD 567 (IQR: 299-1144). The incidence of catastrophic costs had a dose response with household expenditure. The poorest quintile was 6.2 times [95% confidence intervals (CI): 4.0-9.7] more likely to incur catastrophic costs compared to the richest. The prevalence of catastrophic costs decreased with increasing household expenditure quintiles (proportion of catastrophic costs: 59.7%, 32.9%, 23.6%, 15.9%, and 9.5%) from the lowest quintile (Q1) to the highest quintile (Q5). Other determinants included hospitalization: prevalence ratio (PR) = 2.8 (95% CI: 1.8-4.5) and delayed treatment: PR = 1.5 (95% CI: 1.3-1.7). Protective factors included receiving care at a public health facility: PR = 0.8 (95% CI: 0.6-1.0), and a higher body mass index (BMI): PR = 0.97 (95% CI: 0.96-0.98). Pre TB expenditure, hospitalization and BMI were significant predictors in all sensitivity analysis scenarios. Conclusions There are significant inequities in the occurrence of catastrophic costs. Social protection interventions in addition to existing medical and public health interventions are important to implement for patients most at risk of incurring catastrophic costs. Graphic abstract Keywords: Tuberculosis, Health expenditure, Income loss, Social protection, Kenya